التفاصيل البيبلوغرافية
العنوان:
Implications for management of ovarian cancer in a transgender man: Impact of androgens and androgen receptor status
المؤلفون:
Sarah Glaze , Fiona Mattatall , Gregg Nelson , Christa Aubrey , Martin Köbel , Nathalie Saad
المصدر:
Gynecologic Oncology . 161:342-346
بيانات النشر:
Elsevier BV, 2021.
سنة النشر:
2021
مصطلحات موضوعية:
Adult , Male , 0301 basic medicine , Oncology , medicine.medical_specialty , Paclitaxel , Adjuvant chemotherapy , medicine.medical_treatment , Salpingo-oophorectomy , Antineoplastic Agents , Transgender Persons , Carboplatin , 03 medical and health sciences , 0302 clinical medicine , Internal medicine , Antineoplastic Combined Chemotherapy Protocols , Transgender , Biomarkers, Tumor , Humans , Medicine , Testosterone , Stage (cooking) , Ovarian Neoplasms , Ovarian Endometrioid Carcinoma , business.industry , Obstetrics and Gynecology , Exogenous testosterone , medicine.disease , humanities , Androgen receptor , 030104 developmental biology , Chemotherapy, Adjuvant , Receptors, Androgen , Sex Reassignment Procedures , 030220 oncology & carcinogenesis , Androgens , Female , Hormone therapy , business , Ovarian cancer , Carcinoma, Endometrioid
الوصف:
A 36-year-old transgender man (assigned female at birth) on exogenous testosterone therapy was found to have stage IIA ovarian endometrioid carcinoma, and underwent adjuvant chemotherapy. Diffuse androgen receptor expression in the tumor initiated a multidisciplinary discussion regarding the safety of continuing exogenous testosterone as gender-affirming hormone therapy.
تدمد:
0090-8258
DOI:
10.1016/j.ygyno.2021.02.019
URL الوصول:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d56c016a1d77ae0cc88524737a97447 https://doi.org/10.1016/j.ygyno.2021.02.019
Rights:
OPEN
رقم الانضمام:
edsair.doi.dedup.....9d56c016a1d77ae0cc88524737a97447
قاعدة البيانات:
OpenAIRE